Independent research on the U.S. markets, Baptista Research

Baptista Research

Independent research on the U.S. markets

Baptista Research is an independent financial research house focused on the U.S. markets. We provide equity research as well as credit research reports on the top-listed U.S. companies with most of our focus on technology, consumer goods and services, automobiles, industrials, oil and gas, pharma, and healthcare. Our research has served more than 3000 institutional investors including mutual funds, hedge funds, banks, family offices, and various buy-side firms. We operate a research subscription service where institutions, as well as retail investors, can have priority access to all our research. We also have a wide distribution of our research reports across some of the top global financial platforms. Apart from equity research and credit research, we also provide advisory services with respect to mergers & acquisitions (M&A), private equity/ venture capital fundraising, valuation reports, and investment management services for corporates.
Baptista Research is owned and managed by Ishan Majumdar, an ex-Venture Capitalist/ Investment Banker, a Chartered Accountant, and a Masters’ degree holder in Management from HEC Paris. Ishan has nearly a decade of experience in Mergers and Acquisitions, Leveraged Buyouts (LBOs), Venture Capital Investing, Corporate Strategy, and Valuation in front-office roles at the likes of BNP Paribas CIB, Credit Agricole CIB, Groupe Danone, and TIW Private Equity. He has worked on and closed multiple acquisition deals, leveraged buyouts, and start-up investment transactions.

Equity Bottom-Up

<ul><li>Doximity’s first quarter fiscal 2027 results showed continued revenue growth and increased investment in clinical artificial intelligence.</li><li>Revenue rose 7% year-over-year to $157 million, exceeding the high end of guidance by 3%.</li><li>Adjusted EBITDA reached $75 million, representing a 48% margin and an 8% outperformance versus guidance.</li></ul>

Doximity’s first quarter fiscal 2027 results showed continued revenue growth and increased investment in clinical artificial intelligence.Revenue rose 7% year-over-year to $157 million, exceeding the high end of guidance by 3%.Adjusted EBITDA reached $75 million, representing a 48% margin and an 8% outperformance versus guidance.

Doximity Builds A Physician AI Powerhouse — Ask, Scribe & Decision Support Converge!

Smartkarma AI Primers, Smartkarma

αSK Primers

Smartkarma AI Primers

Smartkarma

Smartkarma unites the fragmented investment industry, connecting institutional investors, independent research providers, and corporates within a single network.

Research Reinvented

<ul>
 <li>
<a href="https://smartkarma.com/entities/doximity-inc-class-a">Doximity</a> has established a dominant network effect, with over 80% of U.S. physicians on its platform, creating a wide economic moat and a highly valuable, targeted audience for pharmaceutical and health system clients.</li>
 <li>The company demonstrates a highly profitable and scalable business model, characterized by strong revenue growth, high margins, and robust free cash flow generation, primarily driven by subscription-based marketing and hiring solutions.</li>
 <li>Future growth is expected to be driven by the increasing shift of healthcare marketing budgets from traditional to digital channels, the expansion of telehealth services, and the adoption of new AI-powered tools designed to reduce administrative burdens for clinicians.</li>
</ul>This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


  
Doximity has established a dominant network effect, with over 80% of U.S. physicians on its platform, creating a wide economic moat and a highly valuable, targeted audience for pharmaceutical and health system clients.
  The company demonstrates a highly profitable and scalable business model, characterized by strong revenue growth, high margins, and robust free cash flow generation, primarily driven by subscription-based marketing and hiring solutions.
  Future growth is expected to be driven by the increasing shift of healthcare marketing budgets from traditional to digital channels, the expansion of telehealth services, and the adoption of new AI-powered tools designed to reduce administrative burdens for clinicians.
This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.

<ul><li>During the third quarter of fiscal year 2026, Doximity, a digital platform for medical professionals, showcased strong financial performance and engagement growth across its network.</li><li>The company reported a revenue of $185 million, marking a 10% increase year-over-year and exceeding the higher end of its guidance by 2%.</li><li>The adjusted EBITDA margin was 60%, achieving $111 million, surpassing expectations by 7%.</li></ul>

During the third quarter of fiscal year 2026, Doximity, a digital platform for medical professionals, showcased strong financial performance and engagement growth across its network.The company reported a revenue of $185 million, marking a 10% increase year-over-year and exceeding the higher end of its guidance by 2%.The adjusted EBITDA margin was 60%, achieving $111 million, surpassing expectations by 7%.

Doximity: Integrating Scribe, Telehealth, and EHR Systems Into One Intelligent Platform!

<ul><li>Doximity, Inc. recently reported its fiscal second-quarter earnings for 2026, highlighting both strides in its growth strategy and existing challenges.</li><li>Overall, the company demonstrated strong financial performance and operational expansion, positioning itself as a key player in the digital health space, but it also noted some market uncertainties and risks that could impact future performance.</li><li>On the positive side, Doximity recorded $169 million in revenue, marking a 23% year-over-year increase and exceeding its previous guidance.</li></ul>

Doximity, Inc. recently reported its fiscal second-quarter earnings for 2026, highlighting both strides in its growth strategy and existing challenges.Overall, the company demonstrated strong financial performance and operational expansion, positioning itself as a key player in the digital health space, but it also noted some market uncertainties and risks that could impact future performance.On the positive side, Doximity recorded $169 million in revenue, marking a 23% year-over-year increase and exceeding its previous guidance.

Doximity: Inside the Multimodal Surge — How a 5% Feature Became 40% of Bookings in One Year!

Podcast by Dom Cooke to explore big businesses, Business Breakdowns

Business Breakdowns

Podcast by Dom Cooke to explore big businesses

Learn how companies work from the people who know them best. We do deep research and interview industry veterans, investment professionals, and corporate executives to explain the inner workings of public stocks and private businesses. For each company, we break down their history, business model, financial statements, secret sauce, and bull/bear case. We believe every business has lessons to teach us and Breakdowns is here to highlight them. Learn more and stay up to date at www.joincolossus.com.

<ul><li>Business Breakdowns is a series diving deep into a single business</li><li>Doximity is a B2B media business for medical professionals</li><li>Community engine, social network, and tools make life easier for medical professionals</li></ul>This content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only.

Business Breakdowns is a series diving deep into a single businessDoximity is a B2B media business for medical professionalsCommunity engine, social network, and tools make life easier for medical professionalsThis content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only.

Doximity: The Hub of Healthcare - [Business Breakdowns, EP.236]

United States

Doximity, Inc. develops an online healthcare resource and interactive platform. The Company cloud-based platform which enables its members to collaborate with their colleagues, securely coordinate patient care, and conducts virtual patient visits. Doximity serves customers in the United States.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Doximity (DOCS US)

Doximity Builds A Physician AI Powerhouse — Ask, Scribe & Decision Support Converge!

Doximity’s first quarter fiscal 2027 results showed continued revenue growth and increased investment in clinical artificial intelligence. Revenue...

Baptista Research

Primer: Doximity (DOCS US) - Aug 2026

Doximity has established a dominant network effect, with over 80% of U.S. physicians on its platform, creating a wide economic moat and a...

αSK Primers

Doximity: Integrating Scribe, Telehealth, and EHR Systems Into One Intelligent Platform!

During the third quarter of fiscal year 2026, Doximity, a digital platform for medical professionals, showcased strong financial performance and...

Baptista Research

Doximity: Inside the Multimodal Surge — How a 5% Feature Became 40% of Bookings in One Year!

Doximity, Inc. recently reported its fiscal second-quarter earnings for 2026, highlighting both strides in its growth strategy and existing...

Baptista Research

Doximity: The Hub of Healthcare - [Business Breakdowns, EP.236]

Portrait Research provides qualitative analysis and custom research reports for businesses, with a focus on Doximity, a B2B media platform for...

Business Breakdowns

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)